Chronic kidney disease as a global public health problem: approaches and initiatives–a position statement from Kidney Disease Improving Global Outcomes AS Levey, R Atkins, J Coresh, EP Cohen, AJ Collins, KU Eckardt, ... Kidney international 72 (3), 247-259, 2007 | 2149 | 2007 |
Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs JL Vanherweghem, C Tielemans, D Abramowicz, M Depierreux, ... The lancet 341 (8842), 387-391, 1993 | 1692 | 1993 |
KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease IH de Boer, ML Caramori, JCN Chan, HJL Heerspink, C Hurst, K Khunti, ... Kidney international 98 (4), S1-S115, 2020 | 965* | 2020 |
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference AS Levey, KU Eckardt, NM Dorman, SL Christiansen, EJ Hoorn, ... Kidney international 97 (6), 1117-1129, 2020 | 699 | 2020 |
Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS RB Fissell, JL Bragg-Gresham, JD Woods, M Jadoul, B Gillespie, ... Kidney international 65 (6), 2335-2342, 2004 | 636 | 2004 |
Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis DRW Jayne, AN Bruchfeld, L Harper, M Schaier, MC Venning, P Hamilton, ... Journal of the American Society of Nephrology 28 (9), 2756-2767, 2017 | 634 | 2017 |
Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults NH Phelps, RK Singleton, B Zhou, RA Heap, A Mishra, JE Bennett, ... The Lancet 403 (10431), 1027-1050, 2024 | 611 | 2024 |
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial HJL Heerspink, HH Parving, DL Andress, G Bakris, R Correa-Rotter, ... The Lancet 393 (10184), 1937-1947, 2019 | 566 | 2019 |
Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study M Jadoul, JM Albert, T Akiba, T Akizawa, L Arab, JL Bragg-Gresham, ... Kidney international 70 (7), 1358-1366, 2006 | 550 | 2006 |
Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS) EW Young, T Akiba, JM Albert, JT McCarthy, PG Kerr, DC Mendelssohn, ... American Journal of Kidney Diseases 44, 34-38, 2004 | 506 | 2004 |
Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference M Ostermann, R Bellomo, EA Burdmann, K Doi, ZH Endre, SL Goldstein, ... Kidney international 98 (2), 294-309, 2020 | 426 | 2020 |
The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference MG Shlipak, SL Tummalapalli, LE Boulware, ME Grams, JH Ix, V Jha, ... Kidney international 99 (1), 34-47, 2021 | 425 | 2021 |
Physical exercise among participants in the Dialysis Outcomes and Practice Patterns Study (DOPPS): correlates and associated outcomes F Tentori, SJ Elder, J Thumma, RL Pisoni, J Bommer, RB Fissell, ... Nephrology Dialysis Transplantation 25 (9), 3050-3062, 2010 | 419 | 2010 |
Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? JP Cosyns, M Jadoul, JP Squifflet, JF De Plaen, D Ferluga, ... Kidney international 45 (6), 1680-1688, 1994 | 407 | 1994 |
Urothelial lesions in Chinese-herb nephropathy JP Cosyns, M Jadoul, JP Squifflet, FX Wese, CY de Strihou American journal of kidney diseases 33 (6), 1011-1017, 1999 | 403 | 1999 |
Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference NH Lameire, A Levin, JA Kellum, M Cheung, M Jadoul, WC Winkelmayer, ... Kidney international 100 (3), 516-526, 2021 | 367 | 2021 |
Large Genomic Rearrangements in the Hepatocyte Nuclear Factor-1β (TCF2) Gene Are the Most Frequent Cause of Maturity-Onset Diabetes of the Young Type 5 C Bellanné-Chantelot, S Clauin, D Chauveau, P Collin, M Daumont, ... Diabetes 54 (11), 3126-3132, 2005 | 341 | 2005 |
Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy S Sethi, H Debiec, B Madden, MC Charlesworth, J Morelle, LA Gross, ... Kidney international 97 (1), 163-174, 2020 | 336 | 2020 |
Peripheral arterial disease in patients with end-stage renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS) S Rajagopalan, S Dellegrottaglie, AL Furniss, BW Gillespie, ... Circulation 114 (18), 1914-1922, 2006 | 334 | 2006 |
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European … PA Sarafidis, A Persu, R Agarwal, M Burnier, P de Leeuw, CJ Ferro, ... Nephrology dialysis transplantation 32 (4), 620-640, 2017 | 312 | 2017 |